|
 |
|
Michael Patane, PhD – Egenix Therapeutics
- Former Executive Director, Global Discovery Chemistry, Novartis
- Former Directory Medicinal Chemistry, Millennium
- Chief Scientific Officer, EyeGate Pharmaceuticals
- Advanced more than 15 compounds to pre-clinical and clinical development
|
|
 |
 |
|
|
David Frank, PhD – Egenix Diagnostics
- 35 years of diagnostics experience at Kodak and Johnson & Johnson
- Ph.D. Cornell University
- Background in Business Development, Marketing, and R&D
- Managing Director, MEDx Associates LLC
|
|
 |
 |
|
|
Lionel Goldfrank III – Financial Advisor
- Founder American and Overseas Asset Services Corporation
- Principal in several private investment companies
- Formerly with Goldman Sachs and Co.
|
|
 |
 |
|
|
David C. Clapp – Financial Advisor
- Lead Director of MBIA, Inc
- Chairman of Arthritis Foundation
- Board member, Bard College, Kent School, and Scenic Hudson Land Trust
- Former General Partner of Goldman Sachs and Co.
|
|
 |
 |
|
|
W. James Tozer, Jr. – Financial Advisor
- President and co-founder of the Vectra Management Group
- Co-founder of Vectra Banking Corporation
- Former director of LendingTree, Inc.
- Former President of Prudential Bache Securities
|
|
 |